557 related articles for article (PubMed ID: 26032833)
1. CGRP as a neuropeptide in migraine: lessons from mice.
Russo AF
Br J Clin Pharmacol; 2015 Sep; 80(3):403-14. PubMed ID: 26032833
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin gene-related peptide (CGRP): a new target for migraine.
Russo AF
Annu Rev Pharmacol Toxicol; 2015; 55():533-52. PubMed ID: 25340934
[TBL] [Abstract][Full Text] [Related]
3. Induction of Migraine-Like Photophobic Behavior in Mice by Both Peripheral and Central CGRP Mechanisms.
Mason BN; Kaiser EA; Kuburas A; Loomis MM; Latham JA; Garcia-Martinez LF; Russo AF
J Neurosci; 2017 Jan; 37(1):204-216. PubMed ID: 28053042
[TBL] [Abstract][Full Text] [Related]
4. Targeting CGRP: A New Era for Migraine Treatment.
Wrobel Goldberg S; Silberstein SD
CNS Drugs; 2015 Jun; 29(6):443-52. PubMed ID: 26138383
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
Bigal ME; Walter S; Rapoport AM
Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
[TBL] [Abstract][Full Text] [Related]
6. [Calcitonin gene-related peptide: a key player neuropeptide in migraine].
Ramos-Romero ML; Sobrino-Mejia FE
Rev Neurol; 2016 Nov; 63(10):460-468. PubMed ID: 27819404
[TBL] [Abstract][Full Text] [Related]
7. CGRP as the target of new migraine therapies - successful translation from bench to clinic.
Edvinsson L; Haanes KA; Warfvinge K; Krause DN
Nat Rev Neurol; 2018 Jun; 14(6):338-350. PubMed ID: 29691490
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine.
Durham PL
Headache; 2008 Sep; 48(8):1269-75. PubMed ID: 18808507
[TBL] [Abstract][Full Text] [Related]
9. Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat.
Edvinsson L; Eftekhari S; Salvatore CA; Warfvinge K
Mol Cell Neurosci; 2011 Jan; 46(1):333-9. PubMed ID: 21040789
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic antibodies against CGRP or its receptor.
Bigal ME; Walter S; Rapoport AM
Br J Clin Pharmacol; 2015 Jun; 79(6):886-95. PubMed ID: 25614243
[TBL] [Abstract][Full Text] [Related]
11. CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine.
Maasumi K; Michael RL; Rapoport AM
Drugs; 2018 Jun; 78(9):913-928. PubMed ID: 29869205
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in behavior and expression of CGRP-related genes in a rodent model of chronic migraine.
Stucky NL; Gregory E; Winter MK; He YY; Hamilton ES; McCarson KE; Berman NE
Headache; 2011 May; 51(5):674-92. PubMed ID: 21521205
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin Gene-Related Peptide-Targeted Therapies for Migraine and Cluster Headache: A Review.
Schuster NM; Rapoport AM
Clin Neuropharmacol; 2017; 40(4):169-174. PubMed ID: 28644160
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of calcitonin gene-related peptide (CGRP) receptors in trigeminal ganglia of R192Q Cacna1a knock-in mice.
Vilotti S; Vana N; Van den Maagdenberg AM; Nistri A
Neurosci Lett; 2016 May; 620():104-10. PubMed ID: 27021026
[TBL] [Abstract][Full Text] [Related]
15. CGRP Monoclonal Antibodies for Migraine: Rationale and Progress.
Yuan H; Lauritsen CG; Kaiser EA; Silberstein SD
BioDrugs; 2017 Dec; 31(6):487-501. PubMed ID: 29116598
[TBL] [Abstract][Full Text] [Related]
16. Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP.
Recober A; Kaiser EA; Kuburas A; Russo AF
Neuropharmacology; 2010 Jan; 58(1):156-65. PubMed ID: 19607849
[TBL] [Abstract][Full Text] [Related]
17. Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models.
Avona A; Burgos-Vega C; Burton MD; Akopian AN; Price TJ; Dussor G
J Neurosci; 2019 May; 39(22):4323-4331. PubMed ID: 30962278
[TBL] [Abstract][Full Text] [Related]
18. CGRP receptor antagonists: toward a novel migraine therapy.
Salvatore CA; Kane SA
Curr Pharm Biotechnol; 2011 Oct; 12(10):1671-80. PubMed ID: 21466447
[TBL] [Abstract][Full Text] [Related]
19. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
Edvinsson L
Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
[TBL] [Abstract][Full Text] [Related]
20. TEV-48125: a review of a monoclonal CGRP antibody in development for the preventive treatment of migraine.
Walter S; Bigal ME
Curr Pain Headache Rep; 2015 Mar; 19(3):6. PubMed ID: 25754596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
